New preclinical findings highlight Telomir-1’s ability to reverse CDKN2A gene silencing by DNA methylation, reactivating this gene – often called the body’s natural “cell cycle brake.” These results ...
New in vitro results show Telomir-1 adds KDM5 family inhibition to its previously reported KDM2/KDM6 and DNA methylation ...
A team led by Christian Baumgartner of the Institute of Health Care Engineering at Graz University of Technology (TU Graz) ...
New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint ...
Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced an upcoming poster presentation highlighting the ...
2don MSN
Unfolded protein response pathway offers new targets to treat bone weakness in cancer patients
Before a chain of amino acids can become an active and useful protein, it must be processed and folded into the appropriate ...
A new research paper was published in Volume 17, Issue 8 of Aging-US on August 7, 2025, titled “Senescent cell heterogeneity ...
Circadian rhythms regulate the sleep-wake cycle, hormone secretion, metabolism, immune responses, and even patterns of eating and digestion. They help preserve genomic stability, control the cell ...
News-Medical.Net on MSN
Senescent cell subtypes do not respond equally to treatment, study shows
A new research paper was published in Volume 17, Issue 8 of Aging-US on August 7, 2025, titled "Senescent cell heterogeneity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results